India covid-19 RNA vaccine Government India

Explainer: All that you need to know about India’s first covid-19 vaccine

Reading now: 290
www.livemint.com

Everyone seems delighted about the news about the vaccine. What’s the good news?AstraZeneca and Oxford experimented with two different dosing regimens.

One regimen demonstrated an efficacy of 90% when AZD1222 was given as a half dose followed by a full dose one month later. The second regimen showed 62% efficacy when given as two full doses a month apart.

The average efficacy: 70%.So what now?While the trials continue, including the search for an explanation as to why the lower dosage was better, the results allow AstraZeneca and the Serum Institute to approach drug regulators for emergency licensure.

The question of how long the immunity would last after the vaccine is administered is yet to be answered.Why does this vaccine matter more.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA